The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis
Open accessAbstract
Background & Aims The incidence of colorectal cancer (CRC) is increasing in the United States among adults younger than the age of 50 years. Studies of young‐onset CRC have focused on outcomes and treatment patterns. We examined patient presentation, provider evaluation, and time to diagnosis, which can affect stage and prognosis. Methods In a retrospective study, we collected data from patients with a diagnosis of colorectal adenocarcinoma, confirmed by pathologists, seen at the Stanford Cancer Institute from January 1, 2008, through December 31, 2014. We compared symptoms, clinical features, time to diagnosis, and cancer stage in patients with young‐onset CRC (diagnosed at an age younger than 50 years; n = 253) with patients diagnosed with CRC at an age of 50 years or older (n = 232). Results A higher proportion of patients with young‐onset CRC were diagnosed with advanced‐stage tumors (72%) compared with older patients (63%) (P = .03). Larger proportions of patients with young‐onset CRC also had a family history of CRC (25% vs 17% in older patients; P = .03), confirmed or probable hereditary cancer syndromes (7% vs 1% in older patients; P < .01), and left‐sided disease (distal colon cancer in 41% vs 34% in older patients; P = .01; and rectal cancer in 40% vs 35% in older patients; P = .29). Patients with young‐onset CRC had a significantly longer median time to diagnosis (128 vs 79 days for older patients; P < .05), symptom duration (60 vs 30 days for older patients; P < .01), and time of evaluation (31 vs 22 days; P < .05). In multivariable analyses, time to diagnosis was 1.4‐fold longer for younger than for older patients (P < .01). Among younger patients, those with stage III or IV CRC had shorter durations of symptoms and evaluations than those with stage I or II CRC. Conclusions In a retrospective analysis of patients with CRC, we found that greater proportions of patients younger than 50 years were diagnosed with advanced‐stage tumors than older patients; this difference could not be explained simply by delays from symptom onset to diagnosis. Although tumor biology may be an important determinant of stage at diagnosis, clinicians should be aware of CRC alarm symptoms, family history, and genetic syndromes, to speed evaluation and diagnosis of younger patients and potentially improve outcomes. It remains to be determined whether subgroups of persons at risk for young‐onset CRC who benefit from early screening can be identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hapeman, D. E. (1991) · Technometrics · doi:10.1080/00401706.1991.10484817 · Cited by 9,373
Agresti, A. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/0471249688 · Cited by 6,746
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Bailey, C. E., Hu, C.-Y., You, Y. N., Bednarski, B. K., Rodriguez-Bigas, M. A., Skibber, J. M., Cantor, S. B., & Chang, G. J. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.1756 · Cited by 1,077
The distinctive biology of cancer in adolescents and young adults
on behalf of the Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology, Bleyer, A., Barr, R., Hayes-Lattin, B., Thomas, D., Ellis, C., & Anderson, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2349 · Cited by 660
Categorical Data Analysis, Second Edition
Chimka, J. R. (2003) · IIE Transactions · doi:10.1080/07408170304423 · Cited by 605
Increase in Incidence of Colorectal Cancer Among Young Men and Women in the United States
Siegel, R. L., Jemal, A., & Ward, E. M. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0186 · Cited by 479
The Increasing Incidence of Young-Onset Colorectal Cancer: A Call to Action
Ahnen, D. J., Wade, S. W., Jones, W. F., Sifri, R., Mendoza Silveiras, J., Greenamyer, J., Guiffre, S., Axilbund, J., Spiegel, A., & You, Y. N. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.09.006 · Cited by 448
Chang, D. T., Pai, R. K., Rybicki, L. A., Dimaio, M. A., Limaye, M., Jayachandran, P., Koong, A. C., Kunz, P. A., Fisher, G. A., Ford, J. M., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.61 · Cited by 352
Young-Onset Colorectal Cancer: Is It Time to Pay Attention?
You, Y. N. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.602 · Cited by 273
Mork, M. E., You, Y. N., Ying, J., Bannon, S. A., Lynch, P. M., Rodriguez-Bigas, M. A., & Vilar, E. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4503 · Cited by 260
Colorectal cancer outcomes and treatment patterns in patients too young for average‐risk screening
Abdelsattar, Z. M., Wong, S. L., Regenbogen, S. E., Jomaa, D. M., Hardiman, K. M., & Hendren, S. (2016) · Cancer · doi:10.1002/cncr.29716 · Cited by 256
A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer
Antelo, M., Balaguer, F., Shia, J., Shen, Y., Hur, K., Moreira, L., Cuatrecasas, M., Bujanda, L., Giraldez, M. D., Takahashi, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045357 · Cited by 249
Do Young Colon Cancer Patients Have Worse Outcomes?
O’Connell, J. B., Maggard, M. A., Liu, J. H., Etzioni, D. A., Livingston, E. H., & Ko, C. Y. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7306-7 · Cited by 247
Population-Based Family History–Specific Risks for Colorectal Cancer: A Constellation Approach
Taylor, D. P., Burt, R. W., Williams, M. S., Haug, P. J., & Cannon–Albright, L. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.044 · Cited by 235
Dozois, E. J., Boardman, L. A., Suwanthanma, W., Limburg, P. J., Cima, R. R., Bakken, J. L., Vierkant, R. A., Aakre, J. A., & Larson, D. W. (2008) · Medicine · doi:10.1097/md.0b013e3181881354 · Cited by 210
Lowery, J. T., Ahnen, D. J., Schroy, P. C., Hampel, H., Baxter, N., Boland, C. R., Burt, R. W., Butterly, L., Doerr, M., Doroshenk, M., et al. (2016) · Cancer · doi:10.1002/cncr.30080 · Cited by 186
Self-citationClinical and molecular features of young-onset colorectal cancer
Ballester, V. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i5.1736 · Cited by 182
Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care
Tørring, M. L., Frydenberg, M., Hansen, R. P., Olesen, F., Hamilton, W., & Vedsted, P. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.60 · Cited by 160
Young Age Influences Treatment but not Outcome of Colon Cancer
Quah, H. M., Joseph, R., Schrag, D., Shia, J., Guillem, J. G., Paty, P. B., Temple, L. K. F., Wong, W. D., & Weiser, M. R. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9465-x · Cited by 131
Myer, P. A., Mannalithara, A., Singh, G., Singh, G., Pasricha, P. J., & Ladabaum, U. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.199 · Cited by 86
Self-citationLimburg, P. J., Harmsen, W. S., Chen, H., Gallinger, S., Haile, R. W., Baron, J. A., Casey, G., Woods, M. O., Thibodeau, S. N., & Lindor, N. M. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.10.021 · Cited by 71
Diagnosis of colon cancer differs in younger versus older patients despite similar complaints.
Ben‐Ishay, O., Brauner, E., Peled, Z., Othman, A., Person, B., & Kluger, Y. S. (2013) · PubMed · Cited by 32
Age differences in presentation, diagnosis pathway and management of colorectal cancer
Esteva, M., Ruiz, A., Ramos, M., Casamitjana, M., Sánchez-Calavera, M. A., González-Luján, L., Pita‐Fernández, S., Leiva, A., Pértega-Díaz, S., Costa-Alcaraz, A. M., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.05.002 · Cited by 30
Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer
Tezcan, G., Tunca, B., Ak, S., Cecener, G., & Egeli, U. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i1.83 · Cited by 29
The conundrum of the young colon cancer patient
Amri, R., Bordeianou, L., & Berger, D. L. (2015) · Surgery · doi:10.1016/j.surg.2015.07.018 · Cited by 27
Micromanaging the Classification of Colon Cancer: The Role of the microRNAome
Vilar, E., Tabernero, J. M., & Gruber, S. B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2440 · Cited by 14
Cited by
Colorectal cancer statistics, 2023
Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21772 · Cited by 3,733
Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H., & Boland, C. R. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00426-x · Cited by 812
Rising incidence of early-onset colorectal cancer — a call to action
Akimoto, N., Ugai, T., Zhong, R., Hamada, T., Fujiyoshi, K., Giannakis, M., Wu, K., Cao, Y., Ng, K., & Ogino, S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00445-1 · Cited by 728
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., & Wender, R. C. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21557 · Cited by 701
Is early-onset cancer an emerging global epidemic? Current evidence and future implications
Ugai, T., Sasamoto, N., Lee, H.-Y., Ando, M., Song, M., Tamimi, R. M., Kawachi, I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., et al. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00672-8 · Cited by 603
Metadata
- Authors
- Chen, F. W., Sundaram, V., Chew, T. A., & Ladabaum, U.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 15
- Issue
- 5
- Pages
- 728-737.e3
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2553412673
- Cited by
- 295
- References
- 27
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.